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Abstract 
The current focus in organometallic chalcones is based upon their synthesis, eloectrochemical 
properties , diverse biological behavior and their facet towards a new field 
“bioorganometallics’’ concerning both organometallic and coordination chemistry .  The 
organometallic chalcones can be used as precursor for the synthesis of various other 
important biologically active heterocyclic compounds.  Ferrocene based derivatives which 
are one of the most extensively studied among metallocenes has also been reported for their 
application to materials particularly in designing molecular sensors, molecular ferromagnet, 
electrochemical agent, molecular switch and non-linear optical material.  Recently, phosphine 
chemistry has gained attention due to their tremendous applications and aspects in the field 
bioorganometallics.  In view of their enormous prospect we carried out the synthesis and 
characterization of phosphine substituted multimetallic organometallic chalcone.  The 
electrochemical and biological properties of synthesized organometallic chalcone is under 
investigation. 
 
 
 
 
 
 
 
  
 
 
CHAPTER 1 
INTRODUCTION 
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1.1 .  Metal cyclopentadienyl compound 
 A metal cyclopentadienyl compound is a metal complex where a metal binds with one or 
more electron rich cyclopentadienyl groups (C5H5−, abbreviated as Cp−).  Cp generally co-
ordinates in the η5-mode and it can adopt seldom the η1-and η3-co-oridnation mode as shown in 
Figure 1.1   
M M  
Figure 1: η1 and η5 modes of cyclopentadienyl bonding 
 
 Based on the type of bonding between the metals and the cyclopentadienyl moieties, 
metal-cyclopentadienyl complexes are classified into the following three categories: 
a) π-complexes:  Metals and cyclopentadienyl moieties connected by π-bonds are called π-
complexes.  π-complexes, especially in the η5-type coordination mode, are the most typical of the 
three types of complexes.  η3-type π-complexes are also observed, depending on the electronic 
configuration of the metal centre.  In this mode, three carbon atoms are bonded to the metal as an 
allyl-anion ligand, and the remaining two carbon of the Cp ring remains like a simple alkene. 
b) σ-complexes:  σ-complexes have a direct σ-bond between the metal and one of the carbons of 
the cyclopentadienyl group.  
c) Ionic complexes:  Ionic complexes primarily involve alkali metal cations and alkali earth 
metals cations connected to cyclopentadienyl anions.  These complexes are not ionic, but the 
bonding is highly polar and often η1 bonding is indicated.  Ionic type complexes are generally 
synthesized directly by reaction of cyclopentadiene and the metal in a non-aromatic solvent.  
These complexes can be good starting materials for several π-type cyclopentadienyl complexes. 
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1.2.  Sandwich compounds 
 When the two Cp rings are parallel to each other with the metal atom in between, then the 
complex is known as sandwich compound (Figure 2 and Figure 3).  The term sandwich 
compound was introduced in organometallic nomenclature by J.D. Dunitz, L.E. Orgel and R.A. 
Rich during 1950.2 
 
Figure 2: Sandwich compound 
Metallocenes are the special class of sandwich compounds with the general formula (C5H5)2M or 
Cp2M, where two cyclopentadienyl anions (Cp, which is C5H5-) bound to a metal center (M) in 
the oxidation state II.  Metal cyclopentadienyl compounds can be classified into a variety of 
different compounds on the basis of bonding and structural integrity: sandwich compounds 
(Cp2M), half sandwich or piano stool (CpMLy, y=1-4; unidentate ligand), bent or tilted (Cp2MLx, 
x=1-3; L= unidentate ligand like H, Cl, CO) and multidecker compounds (CpxMy) as shown in 
Figure 3.  
 
1.3.  Ferrocene  
 Ferrocene was the first metallocene discovered by Keally, Pauson and Miller et. al. in 
1951 (Figure 4).3  Ferrocene is an organometallic metallocene compound with the formula 
Fe(C5H5)2 or Cp2Fe, systematically named bis(η5-cyclopentadienyl)iron(II).  The d orbitals on 
Fe2+ in ferrocene are coordinated to the π orbitals on the two cyclopentadienyl radicals to form a 
unique sandwich structure.  The sandwich structure of ferrocene was discovered by G. 
Wilkinson, R. B. Woodward and E. O. Fischer independently in 1951.  According to them, 
ferrocene consists of a “double cone” structure with all five carbon atom of each  
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Figure 3 
 
cyclopentadienyl (Cp) ligands interacting with the Fe metal center.  The unique sandwich 
structure of ferrocene was first predicted by infrared and nuclear magnetic resonance 
spectroscopy and was later confirmed by single crystal X-ray crystallography in 1954.  
Wilkinson and Fischer have been honored the Nobel Prize in 1973 for the successive synthesis of 
ferrocene and its complexes.  At room temperature ferrocene is an air stable orange colored solid 
and it can be oxidized to blue-green ferrocenium cation, [(C5H5)2Fe]+.  Ferrocene behaves like an 
aromatic compound and it is susceptible to direct electrophilic substitution reactions, giving rise 
to a variety of mono and di-substituted ferrocenyl compounds.  It is thermally stable and 
unaffected by water, strong acids and alkalis.  Ferrocene is a fascinating molecule due to its 
remarkable redox properties and high stability in air and in high temperature. 
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Figure 4 Structure of Ferrocene 
 
1.4. Applications of ferrocenyl compounds 
 Chemistry of ferrocene led to numerous applications in the field of organic synthesis, 
homogeneous catalysis, materials science, bio-conjugates, bio-analysis and in bioorganometallic 
chemistry.  Ferrocene behave as a one electron donor by undergoing oxidation to give a stable 
cationic ferrocenium ion.  This led ferrocenyl derivatives to be used as a model for sensors 
and non-linear optical materials.  In contrast to other metallocenes, ferrocenyl compounds is 
more widely employed in drug design due to its special properties like high stability, redox 
property, potential as iron source and low toxicity behavior. 
 
1.4.1. Biological properties of ferrocenyl derivative  
Research is focused on the insertion of ferrocene into drug m o l e c u l e s  t o  bring 
significant change in the drug activities.  Recent report reveals that ferrocenyl derivatives exhibit 
a wide range of biological activity due to its high stability and nontoxic behavior.  Many 
ferrocenyl compounds show interesting cytotoxic, a n t i - m i c r o b i a l ,  anti-fungal, anti-
malarial, anti-cancer and DNA cleaving activities.4-6 
Edward’s research group have synthesized a series of antibiotics containing ferrocene 
moiety such as ferrocenyl penicillin, ferrocenyl cephalosporine and ferrocenyl hybrid of 
penicillin and cephalosporine (Figure 5).7-9 
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Incorporation of ferrocenyl fragments into drugs like chloroquine and tamoxifen, results in 
significant change in activity (Figure 6 and Figure 7).  Ferroquine, a ferrocenyl derivative of 
choloquine is currently the most advanced organometallic drug candidate, which is ready to use 
in phase III clinical trials as antimalarial drug.10,11 
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Figure 6 
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Ferrocifen, derivative of tamoxifen, i s  known as  the first molecules which is active 
against both hormone dependent and hormone independent breast cancer cells.12 
 
H3CH2C
X
OCH2CH2NH(CH3)2
H3CH2C
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OCH2CH2NH(CH3)2
Fe
Tamoxifen (X= H)
Hydroxy derivative of tamoxifen (X=OH) Ferrocifen
 
Figure 7 
Some ferrocenyl hydrazone compounds are recently investigated which display 
antiproliferative effects on A2780 ovarian carcinoma cell line comparable to that produced by 
cisplatin.13 
Quirante et. al. have synthesized and characterized a series of ferrocene-indole hybrids 
and their organic analogues as shown in Figure 8 and have revealed their cytotoxic and moderate 
antimalarial activity.  They have reported some of the ferrocenylindole hybrids showing 
excellent in vitro activities against the A549 human carcinoma cell line, with IC50 values of 5 
and 7 mM respectively.  These ferrocenylindole compounds were up to 25-fold more potent as 
cytotoxic agents than their purely organic analogues.14 
 
 
X=N, R1, R2 = H 
X=H, R1=H, R2=H / Cl / F
X=H, R1=OCH3 / NO2 / Cl, R2=H
XNH
Fe
R1
R2
 
Figure 8  
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In recent times, some symmetrical and unsymmetrical ferrocenyl hydrazones with their 
significant antibacterial activity against B. subtilis, E. coli, S. aureus, K. pneumoniae and P. 
aeruginosa have been explored by our group with moderate to high activity. 15 
Pejovic´ et al. have synthesized ferrocene containing quinolinones and have studied their 
electrochemical as well as their antimicrobial activity towards pathogenic bacteria and one yeast 
with MIC values ranging from 0.01-10 µg/ml lower than that of tetracycline (Figure 9).16 
 
N
Fe
O
H
X
a) X= H, b) X=Cl, c) X=Br
 
 Figure 9 
 
1.4.2.  Ferrocenyl derivatives used as catalyst 
 Ferrocene based ligands have received considerable attention due to their versatile 
coordination properties and numerous successful applications in catalysis17,18.   
Stepnicka et. al. have synthesized (1,9-diphenylphosphino)-1’-[(diphenylphosphino) 
methyl] ferrocene (Figure 10) as an unsymmetric dppf congener and have reported the 
coordination and catalytic study aimed at a comparison of this new donor with the well–studied 
dppf.19 
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To understand the specific challenges of organocatalysis in terms of kinetic rates and 
efficiency, Miniere et. al. have synthesized some new ferrocenyl sulfides, exhibiting planar 
chirality as illustrated in Scheme 1.  Incorporation of various heteroatom groups were done and 
have been evaluated as catalysts for the asymmetric epoxidation of aldehydes via sulfonium 
ylides.20 
NaOH: NaI(2:1)
t-BuOH/H2O (9:1)
            rt
Fe
S
R
R
C
O
HPh
+ +
PhCH2Br
O
PhPh
 
Scheme 1 
 
1.4.3  Electrochemical, optical and sensing properties of ferrocenyl derivatives 
 Recently, Thakur and coworkers21 have reported the electrochemical, optical, and cation-
sensing properties of two synthesized triazole-tethered ferrocenyl benzylacetate derivatives 
(Figure 11).  The binding properties of both the receptors can be inferred either from a redox 
shift (A: ΔE1/2 = 106 mV for Hg2+ and ΔE1/2 = 187 mV for Ni2+; B: ΔE1/2 = 167 mV for Hg2+ and 
ΔE1/2 = 136 mV for Ni2+) or a highly visual output response (colorimetric) for Hg2+, Ni+2, and 
Cu2+ cations.  The redox and colorimetric responses toward Hg2+ are preserved in the presence of 
water, which can be used for the selective colorimetric detection of Hg2+ in an aqueous 
environment over Ni+2and Cu2+ cations.  The changes in the absorption spectra are accompanied 
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by the appearance of a new low-energy peak at 625 nm for both compounds A and B due to a 
change in color from yellow to purple for Hg2+ cations in CH3CN/H2O.  The ferrocene-based 
triazole ligand is the rare example of a dual electrochemical−optical Ni2+ ion sensor in which the 
Fc/Fc+ redox couple is significantly shifted (ΔE1/2 = 187 mV) on complexation, with a concurrent 
change in color from yellow to blue which permits its potential use for “naked eye” detection. 
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Figure 11 
In 2013, Romero et al have synthesized a number of mono and di substituted ferrocene 
based triazoles by copper catalyzed click reactions and have studied their optoelectronic 
properties.  Some of the compounds are optically active molecular sensors for anions such as F-, 
AcO-, H2PO4 -, HP2O7- and some of the compounds behave as dual redox and optically sensors 
for cations such as Hg+2, Pb+2, Ni+2.22 
 
Two ferrocenylchalcones containing the fluorescent anthracenyl group, Ferrocene-
COCH=CH-Anthracene and Anthracene-COCH=CH-Ferrocene, prepared by solvent free aldol 
condensation have been reported by Noh et al.23  The cyclic and differential pulse voltammetry 
analysis showed one reversible cycle corresponding to the Fc/Fc+ and one irreversible peak 
corresponding to the oxidation of anthracenyl group.  The authors also have studied the UV-
Visible spectra of the ferrocenyl chalcones in some solvents of different polarity and have 
concluded that π→π* and n→π* transitions of the enone linkage were not influenced by the 
solvent polarity, but the d→d transition for both Ferrocene-COCH=CH-Anthracene and 
Anthracene-COCH=CH-Ferrocene were shifted by 16nm and 14nm respectively.  So, Ferrocene-
COCH=CH-Anthracene could be used as a non-linear optical (NLO) material due to its strong 
solvatochromic shift. 
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Recently, Trivedi et. al. reported a simple one-pot synthesis, characterization, 
optoelectronic and cation sensing properties of 1-(2-pyridyl)-3-ferrocenylpyrazolines (scheme 2).  
They have described that these ferrocene compounds behave as selective multichannel 
chemosensors in the presence of Co2+, Cu2+, and Zn2+ ions.  A maximum cathodic shift in the 
redox potential of the ferrocenium couple was observed towards the Co2+ ion, while a minimum 
shift was observed with the Zn2+ ion on complexation with this receptor.24 
+ Ar-CHO
1. 20% KOH, r.t.
2.  2-PyNHNH2
Fe
C
N
N
H2C CH
Ar
Fe
O
N
Ar= 1-napthyl, 9-anthryl, 1-pyrenyl
 
Scheme 2 
 
1.4.4.  Ferrocenyl derivatives as a ligand scaffold 
 Chiral ferrocenyl phosphines are used as ligands for transition-metal catalyzed reactions. 
Some of them have found industrial applications in the synthesis of pharmaceuticals and 
agrochemicals.  For example, the diphosphine 1,1'-bis(diphenylphosphino)ferrocene (dppf), 
organophosphorus compound commonly used as a ligand in homogeneous catalysis is a valuable 
ligand for palladium-coupling reactions.   
 
1.5.  Metal Carbonyl chemistry 
 Metal carbonyls are coordination complexes of transition metals with carbon monoxide 
ligands.  They occur as neutral complexes, as positively charged metal carbonyl cations or as 
negatively charged metal carbonylates.  The carbon monoxide ligand may be bound terminally to 
a single metal atom or bridging to two or more metal atoms. 
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1.5.1.  Structure and bonding of metal carbonyls 
 Carbon monoxide bonds to transition metals using "synergistic π  back-bonding."  The 
bonding has three components, giving rise to a partial triple bond.  A sigma bond arises from 
overlap of nonbonding sp-hybridized electron pair on carbon with d-, s-, and p-orbitals on the 
metal.  A pair of π bonds arises from overlap of filled d-orbitals on the metal with a pair of π-
antibonding orbitals projecting from the carbon of the CO.  For the second kind of binding, the 
metal should have d-electrons and have relatively low oxidation state which makes the back 
donation process favorable.  As electrons from the metal fill the π-antibonding orbital of CO, 
they weaken the carbon-oxygen bond compared with free carbon monoxide, while the metal-
carbon bond is strengthened.  The distance between the metal and carbon is relatively short due 
to the multiple bond character of the M-CO linkage.  There are three common types of metal 
carbonyl bonding modes: terminal CO, bridging CO (µ2) and triply bridging CO (µ3) (Figure 12). 
 
M
C
O
M M
C
O
M M
M
C
O
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Figure 12 
Infrared spectroscopy is a sensitive probe for detection of bridging carbonyl ligands and can be 
used for the determination of the type of metal carbonyl bonding in several such compounds.  
Metal carbonyls are important precursors for the synthesis of other organometallic complexes 
and can be used as metal probes and therapeutic agent in medicine.  The half sandwich 
cyclopentadienyltricarbonylmanganese commonly known as cymantrene is an important metal 
carbonyl compound in organometallic chemistry.  Recent research is focused on the properties of 
cymantrenyl derivatives including electrochemical properties and biological activity.15,25-27 
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1.5.2. CO substitution 
 The substitution of CO ligands can be induced thermally or photochemically by donor 
ligands.  Some of the substituting ligands are cyclopentadiene, phosphines, cyanide (CN-), 
olefins, nitrogen donors, and ethers.  Substitution of 18-electron complexes generally follows a 
dissociative mechanism, involving 16-electron intermediates. 
Substitution proceeds via a dissociative mechanism: 
M(CO)n → M(CO)n-1 + CO 
M(CO)n-1 + L → M(CO)n-1L 
Substitution in 17-electron complexes, which are rare, proceeds via associative mechanisms with 
a 19-electron intermediate. 
M(CO)n + L → M(CO)nL 
M(CO)nL → M(CO)n-1L + CO 
Sometime the rate of substitution in 18-electron complexes is sometimes catalyzed by catalytic 
amounts of oxidants, via electron-transfer.  
 
1.6.  Chalcones 
 Chalcones [(Ar–COCH=CH–Ar’)] are the α,β- unsaturated ketones which forms the 
central core for a variety of important biological compounds.  These are colored in nature due to 
the existence of the chromophoric group (-CO-CH=CH-) and depends on the presence of other 
auxochromes.  Chalcones are present in edible plants and constitute one of the major classes of 
natural products with wide range distribution in fruits, vegetables, tea and soy based food stuff.  
Chalcones are present in nature as precursors of flavionoids and as precursors of isoflavionoids.  
Chalcones can be synthesized in the laboratory by various synthetic methods.  The most common 
method used is the condensation of ketone with aromatic aldehyde following Claisen–Schmidt 
reaction as given below in Scheme 3. 
13 
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Scheme 3 
The main functions of some chalcone derivatives in biological system are purifying blood, 
strengthening immune system, monitors cholesterol level, regulates blood pressure, prevents 
thrombus, suppress acid secretion, prevent cancer and promotes metabolism.  Both natural 
chalcones as well as synthetic chalcones have gain the attention of researchers due to their 
pharmacological as well as biological activities such as anti-inflammatory, antifungal, 
antimicrobial , antioxidant, antitumor, cytotoxic, and anticancer activities.29-35 
A plant polyphenol, butein (3, 4, 2', 4'-tetrahydroxychalcone), has been traditionally used 
in some countries for treatment of pain, stomach cancer, thrombotic disease gastritis, parasitic 
infections, as well as a food additive .36,37 
 
In 2010, Chopde and co-workers have synthesized some bioactive chalcones having 8-
hydroxy -quinoline moiety and have shown their moderate activity towards antibacterial study as 
compared to standard drug (Scheme 4).38 
N
OHNH2
COCH3
ZnCl2
EtOH+
N
NH
COCH3
Ar-CHO
EtOH,40% NaOH
N
NH
COCH
H
Ar
 
Scheme 4 
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1.7.  Chalcone containing organometallic tag 
 Recently chalcones containing organometallic fragment are of great interest due to their 
immense applications in the area of biology and medicine.  Ferrocenyl chalcones are chalcones 
in which one or both the aromatic group in the chalcone is replaced by the ferrocenyl group.  The 
chemistry of ferrocenyl chalcone has generated intensive scientific studies throughout the world 
due to their vast applications towards optoelectronic activity, electrochemistry, biology and 
medicine.39-44   
 
1.8.  Applications of organometallic chalcones 
 
1.8.1. Biological activity of organometallic chalcone:- 
 
Major part of the study on ferrocenyl chalcones are based upon their significant biological 
properties.  Ferrocenyl chalcones displays a variety of biological properties such as anticancer, 
anti-inflammatory, antimalarial, anti microbial activities.45-47   A series of novel chalcone 
derivatives have been designed and synthesized, and their biological activities were also 
evaluated as potential inhibitors of tubulin.  These compounds were assayed for in vitro growth-
inhibitory activity against MCF-7 and A549 cell lines.  One of the compounds showed the most 
potent antiproliferative activity against MCF-7 and A549 cell lines with IC50 values of 0.03 and 
0.95 µg /mL and exhibited the most potent tubulin inhibitory activity with IC50 of 1.42 µg /mL 
and can be used as a potential anticancer agent.48   
The facile and efficient synthesis of quinoline-appended ferrocenyl chalcones via the 
condensation of acetylferrocene (or substituted 2-methyl-3-acetylquinoline) with 2-chloro-3-
formylquinoline (or ferrocenecarboxaldehyde) in ethanol under basic conditions by the ultrasonic 
method is reported by Prasath et. al. (Figure 13).49  Redox chemistry of the new chalcones was 
investigated by cyclic voltammetry which showed quasi-reversible one-electron redox processes 
with potentials correlated with electron-withdrawing substituents.  The compounds showed 
promising antimicrobial properties. 
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1.8.2.  Electrochemical properties of organometallic chalcones 
 
Ferrocenyl chalcones can be tuned for different significant properties for the redox 
behaviour of ferrocene group present in it.  Based upon this research has also been focused on 
the study of electrochemistry of ferrocenyl chalcone derivatives. 
E. Erasmus50 has synthesized some chalcones containing diphenyl group, chalcones 
containing one organometallic moiety such as ferrocene or ruthenocene and chalcones having 
two organometallic moieties or both as shown in Scheme 5.  It was observed from UV/Vis 
spectra of the chalcones, that the compounds having a ferrocenyl moiety exhibited two 
absorption bands, where as the compounds having a ruthenocenyl moiety showed one absorption 
band.  Cyclic voltammetry of the compounds revealed a chemically and electrochemically 
reversible Fc/Fc+ couple and an irreversible Rc/Rc2+ couple as it showed no reduction peak.  It 
has been found out that the position of the metallocene closer to the carbonyl or the double bond 
influences the reduction potential of the electroactive metallocenyl moiety in chalcones.  It was 
reported that chalcones with the carbonyl group adjacent to the metallocene are more difficult to 
oxidize than the metallocene adjacent to the double bond. 
O
M
CH3
R H
O
O
M
KOH
M M
O
M= Fc or Ru R = Fc ,Rc or Ph
1: M = Fe
2: M = Ru
3: M = Fe, Fe
4: M = Fe, Ru
5: M = Ru, Fe
6: M = Ru, Ru
 
Scheme 5 
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2.1.  Introduction 
 The current focus in organometallic chalcones is based upon their synthesis, 
eloectrochemical properties and diverse biological behavior.  The organometallic chalcones can 
be used as precursor for the synthesis of various other important biologically active heterocyclic 
compounds.  Recently, phosphine chemistry has gained attention due to their tremendous 
applications and aspects in organometallic and coordination chemistry. 51- 55    
 A new series of hybrid organometallic-organic and dinuclear organometallic chalcones 
containing the cyrhetrenyl fragment were synthesised and characterized by Arancibia et al.  
Evaluation of the compounds for antimalarial activity in vitro against the chloroquine-susceptible 
strain 3D7 and the chloroquine-resistant strain W2 of Plasmodium falciparum, indicated that 
these cyrhetrene conjugates are more active compared to their ferrocenic analogues.56 
 Novel chiral monodentate phosphite ligands holding cymantrene fragment (Figure 14) 
have been prepared by Lyubimov et al.  The phosphate substituted cymantrene compound 
provided higher enantioselectivity than its unsubstituted analogue and was a better asymmetric 
catalyst in hydrogenation of (Z)-methyl-2-acetamido-3-phenylacrylate. 57 
Mn
OC
CO
PPh3
O
O
P O
 
Figure 14 
 
 Nabavizadeh et al. have synthesized a series of cyclometalated diplatinum(II) complexes 
each containing a 1,1'-bis(diphenylphosphino)ferrocene (dppf) spacer ligand using a general 
synthetic approach involving the ligand replacement from the corresponding precursor having a 
labile ligand SMe2.  The kinetic and mechanistic investigation on the related replacement 
reactions have been carried out by using UV-visible and NMR spectroscopies.  The absorption 
and electroluminescence spectroscopic studies of the complex showed interesting photophysical 
properties (Figure 15).58 
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Figure 15 
Some of these interesting features related to organometallic chalcones and phopshine moieties 
have prompted us to investigate in detail the chemistry of organometallic chalcones towards 
phosphine substitution and their influence in navigating interesting properties like 
electrochemical and biological behavior. 
 
2.2. EXPERIMENTAL SECTION 
2.2.1. General Procedures 
 All reactions and manipulations were carried out under an inert atmosphere of dry, pre-
purified nitrogen using standard schlenk line techniques.  Solvents were purified, dried and 
distilled under nitrogen atmosphere prior to use.  Infrared spectra were recorded on a Perkin 
Elmer Spectrum RX-I spectrometer as dichloromethane solutions in 0.1 mm path lengths KBr 
cell and NMR spectra on a 400 MHz Bruker spectrometer in CDCl3.  HPLC grade dichloro 
methane is used for all spectroscopic analysis.  TLC plates (20x20 cm, Silica gel 60 F254) were 
purchased from Merck.  The compound [(η5-C5H5)Fe(η5-C5H4) CH=CHCO(η5-C5H4)Mn(CO)3] 
(1) was synthesized and characterized according to the procedure established by our research 
group.  
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2.2.2. Synthesis of [(η5-C5H5)Fe(η5-C5H4) CH=CH CO(η5-C5H4)Mn(CO)2PPh3] (2)  
 In a two necked round bottom flask compound (1) (0.01gm, 0.025mmol) was taken with 
THF and was stirred in room temperature under nitrogen atmosphere.  To this reaction mixture, 
PPh3 (0.013gm, 0.05mmol) was added and was irradiated with ultraviolet light under nitrogen 
atmosphere in room temperature for 10 minutes under ice cooled condition.  The reaction 
mixture was then stirred for 17 hours in room temperature under nitrogen atmosphere.  The 
reaction was monitored by TLC.  On completion of the reaction, the solution was dried under 
vacuum and the residue was dissolved in dichloromethane solvent and subjected to 
chromatographic work- up using preparative TLC.  Elution with hexane/dichloromethane (40:60) 
solvent mixture separated the following compounds in order of elution : colorless triphenyl 
phosphine, unreacted [(η5-C5H5) Fe(η5-C5H4) CH=CH CO(η5-C5H4)Mn(CO)3 ](1) and an 
orange colored compound [(η5-C5H5) Fe(η5-C5H4) CH=CH CO(η5-C5H4)Mn(CO)2PPh3] (2). 
2 : IR (CO, cm-1, CH2Cl2) 1935 (s), 1876(s), 1645(vs).  1H NMR (, CDCl3): 4.18 (t, η5-C5H5 
(Fc), 5H), 4.47 (t, η5-C5H4 (Fc), 2H), 4.59 (t, η5-C5H4 (Fc), 2H), 5.24 (t, η5-C5H4 (Mn), 2H), 5.32 
(t, η5-C5H4 (Mn), 2H), 6.61 (d, CH=, 2H), 7.38-7.5 (m, Ph, 15H) 7.74 (d, =CH, 2H).  31P NMR 
(, CDCl3): 90.1 
. 
 
2.3. Results and discussion 
 UV irradiation of Compound 1 with PPh3 in THF solvent and subsequent stirring at room 
temperature gave an orange colored compound 2, which was isolated and purified by Thin Layer 
Chromatography using pet -ether and dichloromethane solvent mixture in 40:60 ratio (Scheme 
6).  Spectroscopic characterizations have been carried out with the pure isolated compound.  
Infrared spectrum of 2 shows peaks corresponding to terminal metal carbonyls in the region 
1934-1874 cm-1 and ketonic CO at 1645 cm-1.  The peak pattern for metal carbonyls is exactly 
similar to phosphine mono substituted cymantrene derivative.  1H NMR spectra reveals the 
presence of unsubstituted and substituted ferrocenyl Cp protons at 4.18 (s) and 4.47 (t), 
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4.59 (t) respectively.  Peaks corresponding to cymantrenyl Cp protons have been obtained in 
the region 5.25 (t) and 4.16 (t).  The two olefinic CH protons have been obtained as a 
doublet at 6.61 and 7.74 region.  The more downfield doublet may be assigned for the CH 
close to C=O unit.  Multiplet in the region 7.35-7.5 for 15 protons reveals the presence of 
phenyl rings attached to phosphorus.  31P NMR spectrum shows the presence of peak at 90.1 
corresponding to the only phosphorous atom in the compound. 
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3.  CONCLUSION 
Some novel phosphine and ferrocenyl diphosphine substituted organometallic chalcones 
containing both ferrocenyl and cymantrenyl moieties have been prepared and are characterized 
b y  FT IR ,  1 H  N M R  a n d  31P N M R  s p e c t r o s c o p y .  Reaction with monodentate 
triphenylphosphine gave only one phosphine substituted compound, while the reaction with 
diphosphine (dppf) results in the formation of two different phosphine substituted chalcones.   
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5.  Annexure 
 
IR spectroscopy of compound 2 
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1H NMR of compound 2 
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31P NMR of compound 2 
 
 
 
 
 
 
